siRNA and the lung: research tool or therapeutic drug?
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 8 (3) , 280-285
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Delivering silence: advancements in developing siRNA therapeutics.2008
- Delivery Vehicles for Small Interfering RNA In VivoHuman Gene Therapy, 2008
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencingBiomaterials, 2007
- RNAi therapeutics: a potential new class of pharmaceutical drugsNature Chemical Biology, 2006
- RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle SystemMolecular Therapy, 2006
- Silencing of Fas, but Not Caspase-8, in Lung Epithelial Cells Ameliorates Pulmonary Apoptosis, Inflammation, and Neutrophil Influx after Hemorrhagic Shock and SepsisThe American Journal of Pathology, 2005
- Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 geneNature Medicine, 2004
- Inhibition of respiratory viruses by nasally administered siRNANature Medicine, 2004
- Inhibition of influenza virus production in virus-infected mice by RNA interferenceProceedings of the National Academy of Sciences, 2004